Replies to post #122768 on Biotech Values

[DewDiligence]

A pill versus a shot in the outpatient setting has huge and obvious advantages.

Only for primary VTE prevention. As noted in #msg-64848575, the new oral anticoagulants are not well suited for secondary VTE prevention and have not shown compelling data in that indication.